Commentary on an article by Hannu T. Aro, MD, PhD, et al.: "Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation".
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 21454741.
- Also identified by DOI 10.2106/JBJS.K.00262 and PMC identifier 3084494.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This commentary was updated on April 15, 2011, because of a previous error. In the third paragraph, the sentence that had previously read “In the SPRINT, the two groups of open fractures were associated with statistically equivalent reoperation rates, but there was a trend toward better healing in the open fracture group treated with reamed intramedullary nailing.” now reads “In the SPRINT, the two groups of open fractures were associated with statistically equivalent reoperation rates, but there was a trend toward better healing in the open fracture group treated with unreamed intramedullary nailing.”
Medical subject headings
- Bone Morphogenetic Proteins
- Fracture Fixation, Intramedullary
- Fracture Healing
- Fractures, Open
- Recombinant Proteins
- Tibial Fractures
- Transforming Growth Factor beta
Anatomy
- tibia